Fig. 3From: KIBRA; a novel biomarker predicting recurrence free survival of breast cancer patients receiving adjuvant therapyRecurrence free survival (RFS) of the study cohort. a RFS according to the overall low KIBRA expression in both cytoplasm and nuclei (p = 0.037). b RFS according to the combination of cellular locations of KIBRA expression (p = 0.05)Back to article page